Iowa Carver College of Medicine Iowa Cardiovascular Summit 2025

• Target Audience: cardiologists and internal medicine clinicians
• Sample video: contact me for sample video
• Information:

1. Overview

Course Date: 2025

2. Learning Objectives

Evaluate fundamental hemodynamics, challenging ECGs, and basic ischemic risks in early-stage heart failure patients.

Implement optimized medical strategies for valvular disease, lipid management, and GLP-1 agonist integration in cardiovascular care.

Assess the efficacy and indications for new and upcoming transcatheter, surgical, and electrophysiology (EP) therapies.

Manage complex cardiovascular cases, including LVAD emergencies, antiplatelet therapy for CAD, and heart transplant arrhythmias.

Discuss the evolving role of artificial intelligence and indications for genetic counseling in current-day cardiovascular medicine.

3. Target Audience

Best for cardiologists and internal medicine clinicians who want updates on heart failure, LVADs, and AI in cardiovascular medicine.

4. Topics

Basics of Hemodynamics in Heart Failure

Early Evaluation of Patients at Risk for Heart Failure

Basics of Cardiac Implantable Electronic Device (CIED)

Basics of Ischemic Evaluation

Challenging ECGs

Transcatheter Interventions

Valves and Arrhythmias

Surgical Interventions

Medical Optimization of Valvular Disease

Anticoagulation in Afib and Left Atrial Appendage Closure

Improving Access to Cardiovascular Medications

Antiplatelets for Coronary Artery Disease (CAD) Patients

GLP-1 and Cardiovascular Disease Treatment

Basic Lipid Management

When to Refer to Genetic Counseling

Channelopathy

Hypertrophic Obstructive Cardiomyopathy- Basic Work-up

When to Refer Patients for Advanced Heart Failure Therapies

LVAD and Arrhythmias

Emergencies with LVAD

Cardiac Arrhythmias in Heart Transplants

What to do for a Cardiac Resynchronization Therapy Non-responder and How to Optimize Device Therapy

New and Upcoming Therapy in Heart Failure

New and Upcoming Therapy in EP

New and Upcoming Therapy in CT Surgery

What is New and Upcoming in Imaging

Artificial Intelligence in Current Day Cardiovascular Medicine

Beta-Blockers after Myocardial Infarction in Patients without Heart Failure

WITHDRAWAL-AF – Outcomes After Staged Withdrawal of Heart Failure Therapy Post-AF Ablation